Log In
BCIQ
Print this Print this
 

Chimigen HBV Vaccine (NU 500)

  Manage Alerts
Collapse Summary General Information
Company Akshaya Bio Inc.
DescriptionMulti-antigen chimeric vaccine
Molecular Target Fc gamma receptor II (FCGR2) (CD32) ; Mannose binding receptor (MBR) (CD206)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat hepatitis B virus (HBV) infection
Regulatory Designation
PartnerNuron Biotech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/12/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today